Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
CPE CONSULTANTS, LLC
 

APhA Pharmacy-Based Cardiovascular Disease Risk Management


APhA’s Pharmacy-Based Cardiovascular Disease Risk Management is an innovative and interactive certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.
 
The goals of this program are to:
 
1. Educate pharmacists on current evidence-based treatment goals and clinical management recommendations for dyslipidemia and hypertension.
2. Familiarize pharmacists with important concepts related to healthful lifestyle changes that focus on cardiovascular disease prevention.
3. Introduce techniques and skills for encouraging patient adherence to prescribed therapies.
4. Ensure pharmacist proficiency in blood pressure measurement technique and point-of-care lipid testing.
5. Enhance pharmacist experience in applying elements of motivational interviewing with respect to medication adherence and lifestyle modifications.
 
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management certificate training program has two components: web-based interactive self-study with assessment and the live seminar with online final assessment. A Certificate of Achievement will be awarded to participants who successfully complete all program components, including an evaluation.

Live Training Seminar will focus on these core areas:
 
1. A case-based approach to cardiovascular disease risk assessment and treatment decisions, managing special situations, treating hypertension in a patient with diabetes, and lifestyle modifications and motivational interviewing.
2. Skills assessments on blood pressure measurement technique and motivational interviewing. Participants will be conducting blood pressure assessments on other participants.
3. A discussion regarding the role of the pharmacist and existing business models for cardiovascular disease risk management services.
 
 
For a complete list of learning objectives and for all APhA accreditation information and policies, please visit APhA’s website, http://www.pharmacist.com/pharmacy-based-cardiovascular-disease-risk-management .
 
 

Date: Jul 18, 2016 07:30 AM - 05:00 PM

Fee

$375.00

CE Hours

20.00

CE Units

2.000

Registration closes on Jul 11, 2016 10:00 PM

Activity Type

  • Practice Based

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
 
The University of Findlay College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of contiuning pharmacy education.

Co-Sponsor(s)

American Pharmacists Association (APhA)

Requirements for CE Credit

Cancelation Policy: A 50% cancelation fee will be processed if cancelation occurs 14 days or less prior to the scheduled event. A 75% cancelation fee will be processed if cancelation occurs 7 days or less prior to the scheduled event. A 25% cancelation fee will be processed after registration regardless of the time frame.
 
The University of Findlay College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and complies with the Accreditation Standards for continuing pharmacy education activities.
 
Continuing Education Activities will have a release date of 02/20/2015 and will expire in 02/20/2018. An online statement of credit is available to participants after completing an evaluation form for each continuing education activity attended.
 
Please note that hard copy statements of credit can no longer be used to report continuing education credits to the State Boards of Pharmacy.
 
ATTENTION! The personal profile you create in the online continuing education learning management system will be used to submit your continuing education credits electronically to CPE Monitor. The information in your profile MUST be accurate. It MUST contain an accurate e-Profile number and your date and month of birth. The e-profile number is a 6 digit code.
 
NABP e-Profile ID Number
Pharmacists and pharmacy technicians with questions regarding the NABP e-Profile or CPE Monitor should refer to the FAQ section on the NABP website (www.nabp.net/programs/cpe-monitor-service) or contact NABP Customer Service: custserv@nabp.net or by phone 847.391.4406.
 
Policy on Faculty and Provider Disclosure
It is the policy of The University of Findlay College of Pharmacy that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of these educational activities, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during the presentations. Detailed disclosure will be made available during the presentations.
 
Americans with Disabilities Act (ADA)
The University Of Findlay College Of Pharmacy fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs
 
 
 
Continuing Pharmacy Education (CPE) Information and Activity Completion Requirements
Initial release date: 02/20/2015; expiration date:  02/20/2018
Activity Type:  Practice-based
Learning Level: 2 — Experience with the topic is recommended, but advanced expertise or specialty practice in the subject area is not necessary. This activity will focus on expanding the learner’s knowledge and application of new and/or more complex information.
Target Audience:  Pharmacists in all practice settings
 
  • Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 12 contact hours of CPE credits (1.2 CEUs).    ACPE Universal Activity Number: 0202-9999-15-001-H04-P
  • Successful completion of the live seminar component involves attending the full live seminar, passing the final assessment with a grade of 70% or higher and completing a skills assessment. Successful completion of this component will result in 8 contact hours of CPE credit (0.80 CEU).    ACPE Universal Activity Number: 0202-9999-15-002-L04-P
 
Once credit is claimed, Statements of Credit will be available online within 24 hours on participant’s CPE Monitor profile at www.nabp.net.  The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s “My Training” page on www.pharmacist.com

 

 

Registration closes on Jul 11, 2016 at 10:00 PM

Registration Closed  

 
This certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.
 
The goals of this program are to:
 
1. Educate pharmacists on current evidence-based treatment goals and clinical management recommendations for dyslipidemia and hypertension.
2. Familiarize pharmacists with important concepts related to healthful lifestyle changes that focus on cardiovascular disease prevention.
3. Introduce techniques and skills for encouraging patient adherence to prescribed therapies.
4. Ensure pharmacist proficiency in blood pressure measurement technique and point-of-care lipid testing.
5. Enhance pharmacist experience in applying elements of motivational interviewing with respect to medication adherence and lifestyle modifications.
 
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management certificate training program has two components: web-based interactive self-study with assessment and the live seminar with online final assessment. A Certificate of Achievement will be awarded to participants who successfully complete all program components, including an evaluation.

Live Training Seminar will focus on these core areas:
 
1. A case-based approach to cardiovascular disease risk assessment and treatment decisions, managing special situations, treating hypertension in a patient with diabetes, and lifestyle modifications and motivational interviewing.
2. Skills assessments on blood pressure measurement technique and motivational interviewing. Participants will be conducting blood pressure assessments on other participants.
3. A discussion regarding the role of the pharmacist and existing business models for cardiovascular disease risk management services.
 
 
For a complete list of learning objectives and for all APhA accreditation information and policies, please visit APhA’s website, http://www.pharmacist.com/pharmacy-based-cardiovascular-disease-risk-management .
 
Continuing Pharmacy Education (CPE) Information and Activity Completion Requirements
Initial release date: 02/20/2015; expiration date:  02/20/2018
Activity Type:  Practice-based
Learning Level: 2 — Experience with the topic is recommended, but advanced expertise or specialty practice in the subject area is not necessary. This activity will focus on expanding the learner’s knowledge and application of new and/or more complex information.
Target Audience:  Pharmacists in all practice settings
 
  • Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 12 contact hours of CPE credits (1.2 CEUs).    ACPE Universal Activity Number: 0202-9999-15-001-H04-P
  • Successful completion of the live seminar component involves attending the full live seminar, passing the final assessment with a grade of 70% or higher and completing a skills assessment. Successful completion of this component will result in 8 contact hours of CPE credit (0.80 CEU).    ACPE Universal Activity Number: 0202-9999-15-002-L04-P
 
Once credit is claimed, Statements of Credit will be available online within 24 hours on participant’s CPE Monitor profile at www.nabp.net.  The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s “My Training” page on www.pharmacist.com

Objectives

  • 1. Educate pharmacists on current evidence-based treatment goals and clinical management recommendations for dyslipidemia and hypertension.
  • 2. Familiarize pharmacists with important concepts related to healthful lifestyle changes that focus on cardiovascular disease prevention.
  • 3. Introduce techniques and skills for encouraging patient adherence to prescribed therapies.
  • 4. Ensure pharmacist proficiency in blood pressure measurement technique and point-of-care lipid testing.
  • 5. Enhance pharmacist experience in applying elements of motivational interviewing with respect to medication adherence and lifestyle modifications.
Date: 07/18/16
Time: 07:30 AM - 05:00 PM

Fee

$375.00

Location

The University of Findlay, Davis Street Building
Registration Closed